Actively Recruiting

Phase 3
Age: 18Years - 90Years
All Genders
NCT05014581

Preventing Cardiovascular Collapse With Vasopressors During Tracheal Intubation

Led by University of Turin, Italy · Updated on 2025-03-28

420

Participants Needed

6

Research Sites

86 weeks

Total Duration

On this page

Sponsors

U

University of Turin, Italy

Lead Sponsor

I

Istituto Di Ricerche Farmacologiche Mario Negri

Collaborating Sponsor

AI-Summary

What this Trial Is About

Tracheal intubation (TI) is associated with a high risk of adverse events in critically ill patients and peri-intubation hemodynamic collapse is the most commonly observed. The primary aim of the PREVENTION trial is to compare the effect of the pre-emptive use of noradrenaline versus no peri-intubation use of noradrenaline on incidence of cardiovascular collapse following TI in adult critically ill patients. Patients with absolute indication or contraindication to vasopressor support will be excluded from this trial. Patients will be randomized 1:1 to a continuous infusion of noradrenaline started before induction titrated according to baseline mean arterial pressure. The primary outcome will be the incidence of cardiovascular collapse. Secondary outcomes will include lowest systolic blood pressure and cardiac arrest within 30 minutes from intubation.

CONDITIONS

Official Title

Preventing Cardiovascular Collapse With Vasopressors During Tracheal Intubation

Who Can Participate

Age: 18Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient is admitted or scheduled for admission to a participating study hospital
  • Planned procedure is tracheal intubation with a provider expected to routinely perform intubation
  • Critical illness requiring intubation for cardiorespiratory failure or neurological impairment
  • Sedation planned with or without neuromuscular blockade
  • Age 18 years or older
Not Eligible

You will not qualify if you...

  • No vasopressors or inotropes at the time of eligibility screening
  • Mean arterial pressure less than 60 mmHg or greater than 120 mmHg at screening
  • Urgency of intubation prevents safe study procedures
  • Intubation during cardiopulmonary resuscitation of a patient in cardiac arrest
  • Participation in another unapproved clinical trial
  • Pregnant or suspected pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

CHU de Nantes

Nantes, France

Not Yet Recruiting

2

Galway University Hospitals

Galway, Ireland

Not Yet Recruiting

3

Humanitas Research Hospital

Rozzano, Milan, Italy

Actively Recruiting

4

University Hospital San Luigi Gonzaga

Orbassano, Turin, Italy, 10043

Not Yet Recruiting

5

ASST Grande Ospedale Metropolitano Niguarda

Milan, Italy

Actively Recruiting

6

Policlinico di Milano

Milan, Italy

Actively Recruiting

Loading map...

Research Team

V

Vincenzo Russotto, MD

CONTACT

A

Antonella Vasamì

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here